India's Gland Pharma rises on US FDA nod for blood pressure drug

Gland Pharma

04/06/2025 06:52

** Gland Pharma's shares GLAD.NS up nearly 2% to 1,618 rupees

** Co gets approval from U.S. Food and Drug Administration for "Angiotensin II Acetate Injection" that would help increase blood pressure in adults

** Eligible for 180 days of generic drug exclusivity - co

** Analysts, on avg, rate GLAD "hold", median PT 1,575 rupees - data compiled by LSEG

** Day's move cuts stock's YTD decline to 9%

 (Reporting by Hritam Mukherjee in Bengaluru)

 ((Hritam.Mukherjee@thomsonreuters.com;))